3-Bromo-4-quinolinamine(CAS: 36825-36-2)

3-Bromo-4-quinolinamine (CAS: 36825-36-2) must comply with the Globally Harmonized System of Classification and Labelling of Chemicals (GHS) for hazard communication. In the European Union, it is regulated under REACH (Registration, Evaluation, Authorisation and Restriction of Chemicals). FDA and EPA have specific requirements for the handling and use of this compound in pharmaceutical and industrial applications.

Alternatives to 3-Bromo-4-quinolinamine include other quinoline derivatives such as 4-chloro-3-quinolinamine and 4-bromo-3-quinolinamine, which can be used as starting materials in similar synthetic routes. These alternatives may offer varying reactivity and solubility properties, making them suitable depending on the specific reaction conditions and desired product.

The market for 3-Bromo-4-quinolinamine is driven by its use in pharmaceuticals and research, particularly in the development of new drugs and diagnostics. Recent research trends focus on its potential as an intermediate in the synthesis of biologically active compounds. The demand is expected to grow with advancements in drug discovery and personalized medicine.

Waste containing 3-Bromo-4-quinolinamine should be collected in appropriate containers and stored separately to prevent environmental contamination. It should be disposed of through professional waste disposal services that comply with local and international regulations. Disposal methods may include incineration or chemical treatment to neutralize the compound before disposal, ensuring environmental safety and regulatory compliance.